Cannabis testing includes measurement of active ingredients and major chemical compounds in the given sample of cannabis. This testing also involves the detection of fungi and bacteria, which could lead to infections if unnoticed.
The Cannabis Testing Market was worth XX billion in 2018 and is forecasted to reach XX billion by 2026, at a CAGR of XX% during the forecast period.
Increase in applications of cannabis in development of medicines such as pain management, increase in regulatory approval of medical cannabis products and ongoing research and development activities are driving the Cannabis Testing Market during the forecast period.
Major factors hindering the Cannabis Testing Market are a high cost associated with cannabis testing equipment and stringent government regulations in some parts of the world for cannabis.
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
